Cargando…

Recent Developments in the Use of Intralesional Injections Keloid Treatment

Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately re...

Descripción completa

Detalles Bibliográficos
Autores principales: Trisliana Perdanasari, Aurelia, Lazzeri, Davide, Su, Weijie, Xi, Wenjing, Zheng, Zhang, Ke, Li, Min, Peiru, Feng, Shaoqing, Zhang, Yi Xin, Persichetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Plastic and Reconstructive Surgeons 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228202/
https://www.ncbi.nlm.nih.gov/pubmed/25396172
http://dx.doi.org/10.5999/aps.2014.41.6.620
_version_ 1782343932369174528
author Trisliana Perdanasari, Aurelia
Lazzeri, Davide
Su, Weijie
Xi, Wenjing
Zheng, Zhang
Ke, Li
Min, Peiru
Feng, Shaoqing
Zhang, Yi Xin
Persichetti, Paolo
author_facet Trisliana Perdanasari, Aurelia
Lazzeri, Davide
Su, Weijie
Xi, Wenjing
Zheng, Zhang
Ke, Li
Min, Peiru
Feng, Shaoqing
Zhang, Yi Xin
Persichetti, Paolo
author_sort Trisliana Perdanasari, Aurelia
collection PubMed
description Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately results in a compromised quality of life and diminished functional performance. Various methods have been implemented to improve keloid scars using both surgical and non-surgical approaches. However, it has proven to be a challenge to identify a universal treatment that can deliver optimal results for all types of scars. Through a PubMed search, we explored most of the literature that is available about the intralesional injection treatment of hypertrophic scars and keloids and highlights both current (corticosteroid, 5-fluorouracil, bleomycin, interferon, cryotherapy and verapamil) and future treatments (interleukin-10 and botulinum toxin type A). The reference lists of retrieved articles were also analysed. Information was gathered about the mechanism of each injection treatment, its benefits and associated adverse reactions, and possible strategies to address adverse reactions to provide reliable guidelines for determining the optimal treatment for particular types of keloid scars. This article will benefit practitioners by outlining evidence-based treatment strategies using intralesional injections for patients with hypertrophic scars and keloids.
format Online
Article
Text
id pubmed-4228202
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Society of Plastic and Reconstructive Surgeons
record_format MEDLINE/PubMed
spelling pubmed-42282022014-11-13 Recent Developments in the Use of Intralesional Injections Keloid Treatment Trisliana Perdanasari, Aurelia Lazzeri, Davide Su, Weijie Xi, Wenjing Zheng, Zhang Ke, Li Min, Peiru Feng, Shaoqing Zhang, Yi Xin Persichetti, Paolo Arch Plast Surg Review Article Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately results in a compromised quality of life and diminished functional performance. Various methods have been implemented to improve keloid scars using both surgical and non-surgical approaches. However, it has proven to be a challenge to identify a universal treatment that can deliver optimal results for all types of scars. Through a PubMed search, we explored most of the literature that is available about the intralesional injection treatment of hypertrophic scars and keloids and highlights both current (corticosteroid, 5-fluorouracil, bleomycin, interferon, cryotherapy and verapamil) and future treatments (interleukin-10 and botulinum toxin type A). The reference lists of retrieved articles were also analysed. Information was gathered about the mechanism of each injection treatment, its benefits and associated adverse reactions, and possible strategies to address adverse reactions to provide reliable guidelines for determining the optimal treatment for particular types of keloid scars. This article will benefit practitioners by outlining evidence-based treatment strategies using intralesional injections for patients with hypertrophic scars and keloids. The Korean Society of Plastic and Reconstructive Surgeons 2014-11 2014-11-03 /pmc/articles/PMC4228202/ /pubmed/25396172 http://dx.doi.org/10.5999/aps.2014.41.6.620 Text en Copyright © 2014 The Korean Society of Plastic and Reconstructive Surgeons http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Trisliana Perdanasari, Aurelia
Lazzeri, Davide
Su, Weijie
Xi, Wenjing
Zheng, Zhang
Ke, Li
Min, Peiru
Feng, Shaoqing
Zhang, Yi Xin
Persichetti, Paolo
Recent Developments in the Use of Intralesional Injections Keloid Treatment
title Recent Developments in the Use of Intralesional Injections Keloid Treatment
title_full Recent Developments in the Use of Intralesional Injections Keloid Treatment
title_fullStr Recent Developments in the Use of Intralesional Injections Keloid Treatment
title_full_unstemmed Recent Developments in the Use of Intralesional Injections Keloid Treatment
title_short Recent Developments in the Use of Intralesional Injections Keloid Treatment
title_sort recent developments in the use of intralesional injections keloid treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228202/
https://www.ncbi.nlm.nih.gov/pubmed/25396172
http://dx.doi.org/10.5999/aps.2014.41.6.620
work_keys_str_mv AT trislianaperdanasariaurelia recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT lazzeridavide recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT suweijie recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT xiwenjing recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT zhengzhang recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT keli recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT minpeiru recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT fengshaoqing recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT zhangyixin recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment
AT persichettipaolo recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment